Data Processing Study Objectics Study Design
© Christian Sticherling, David Conen 2019
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the  general population. Due to the demographic change with  increasing life expectancy, the occurrence of AF is expected to  further increase in the near future. Patients suffering from AF are  at risk for serious complications, such as a 4-5 fold higher risk of  stroke, and a more than 10-fold higher risk of heart failure  compared to individuals without AF. In addition, recent studies  found a reduced quality of life and increased risk of cognitive  impairments and dementia among AF patients.   Hence, AF has become a major public health problem in  Switzerland. Improving treatment strategies that minimize the risk  of disabling events such as stroke, heart failure or dementia  in this growing patient population will therefore have a substantial  positive impact on public health. Further, improving medical  care and clinical outcomes holds a great potential of being  cost-effective or even cost-saving, as these factors are  significantly associated with costs of care.  


Swiss-AF is funded by the Swiss National Science Foundation (SNSF).
Home Study Overview Background Centers Contact Links